CYCS and Familial prostate cancer: In this study, we further demonstrated that another autophagy inhibitor, Baf A1, increased the disruption of the MMP, the release of cytosolic cytochrome c, and the activity of caspase 3/7 in BITC-treated prostate cancer cells (Figure 5A-5F).